Corporate Information And Statement Of Ifrs Compliance [Abstract]

Cinclus Pharma Holding AB - Filing #5879290

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification
Domicile of entity
Legal form of entity
Address of entity's registered office
Description of nature of entity's operations and principal activities
Statement of IFRS compliance [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade payables
18 928 SEK
16 448 SEK
Disclosure of material accounting policy information [text block]
Explanation of sources of estimation uncertainty with significant risk of causing material adjustment
Disclosure of objectives, policies and processes for managing capital [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.